Evidence – Confidence You Can Measure
Cannulight is proven technology, validated in clinical feedback and with a range of medics.
From clinician trials the results are clear: Cannulight enables higher first-stick success rates and greater clinician confidence. When the green light comes on, uncertainty reduces, and outcomes improve.
By delivering instant confirmation on vein entry, Cannulight enables confidence, reduces missed attempts, and empowers clinicians to act with certainty when it matters most.
90% of clinicians felt more confident using Cannulight after their first try.*
82% said they would use Cannulight on difficult IV access (DIVA) patients.*
47% of clinicians reported they would use it on all patients.*
US Human Factor Validation Test delivered 100% first stick success in manikin arms.
*Cannulight was trialed by 225 clinicians at SOMA 2024 & 2025 (Raleigh, NC), AVA 2024 (Denver, CO), CRiC, IVNNZ conference, AVA Australia and NZ hospitals
** Military Trial 2024 – Details Classified
Evidence That Demands Attention
A global snapshot of IV failure — and what it’s really costing us
Every day, millions of IV lines go in. Yet one in three fails before treatment is complete.
That’s not just discomfort, it’s wasted time, repeat procedures, and escalating costs across the system.
The Cannulight Literature Review (2015–2025) distils data from 70+ studies to reveal the scale of the problem and where first-stick confidence can change everything.
Why It Matters
Fewer attempts → less pain, faster care.
Less escalation → more time for clinicians, fewer machines tied up.
More first-stick success → lower costs, calmer teams.
It’s the evidence base for smarter decisions, from training and procurement to economic modelling and innovation investment.
Download the Review
See the data driving change — and the opportunity to do better.
Free access for clinicians, educators, and healthcare partners.
Who It’s For
Clinicians improving success and patient experience
Simulation and training leaders building real-world readiness
Procurement and policy teams targeting efficiency gains
Researchers and innovators shaping the next generation of vascular access
Disclaimer
This information and accompanying literature review are intended for healthcare professionals. Cannulight is currently approved for sale in New Zealand only and is not cleared or approved by the FDA, CE, or other regulatory bodies outside this jurisdiction.
Cannulight is currently available for purchase and use only in New Zealand. It has not yet been cleared or approved by the US FDA or other international regulatory authorities.
The information on this website is intended for New Zealand audiences only.